CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Vor Biopharma Inc.
Sign in to watch- Ticker
- VOR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 811591163
- Phone
- 617-655-6580
- Business address
- 500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-13 | ANG ROBERT President and CEO | Grant or award | +172,500 | 584,572 | ||
| 2022-09-13 | ANG ROBERT President and CEO | Grant or award · Employee Stock Option (right to buy) | +172,500 | 172,500 | ||
| 2022-09-01 | Chakraborty Tirtha Chief Scientific Officer | Grant or award | +76,000 | 96,980 | ||
| 2022-09-01 | Chakraborty Tirtha Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +76,000 | 76,000 | ||
| 2022-09-01 | Jorgensen Nathan D. Chief Financial Officer | Grant or award | +86,000 | 115,269 | ||
| 2022-09-01 | Jorgensen Nathan D. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +86,000 | 86,000 | ||
| 2022-06-14 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award · Stock Option (Right to Buy) | +16,911 | 16,911 | ||
| 2022-06-14 | Resnick Joshua Director | Grant or award · Stock Option (right to buy) | +16,911 | 16,911 | ||
| 2022-06-14 | Patterson Matthew R Director | Grant or award · Stock Option (right to buy) | +16,911 | 16,911 | ||
| 2022-06-14 | PARMAR KUSH Director | Grant or award · Stock Option (right to buy) | +16,911 | 16,911 | ||
| 2022-06-14 | Lundberg Sven Ante Director | Grant or award · Stock Option (right to buy) | +16,911 | 16,911 | ||
| 2022-06-14 | Lubner David Charles Director | Grant or award · Stock Option (right to buy) | +16,911 | 16,911 | ||
| 2022-06-14 | Beckman Daniella Director | Grant or award · Stock Option (right to buy) | +16,911 | 16,911 | ||
| 2022-02-01 | Slapak Christopher Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +116,000 | 116,000 | ||
| 2022-02-01 | Jorgensen Nathan D. Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +135,000 | 135,000 | ||
| 2022-02-01 | Chakraborty Tirtha Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +101,000 | 101,000 | ||
| 2022-02-01 | ANG ROBERT President and CEO | Grant or award · Employee Stock Option (right to buy) | +376,000 | 376,000 | ||
| 2021-11-16 | 5AM Ventures VI, L.P. 10% owner | Sale | −238,870 | $15.30 | $3.7M | 4,595,089 |
| 2021-11-16 | 5AM Ventures VI, L.P. 10% owner | Sale | −91,836 | $15.30 | $1.4M | 1,766,634 |
| 2021-11-16 | PARMAR KUSH Director | Sale | −238,870 | $15.30 | $3.7M | 4,595,089 |
Page 15 of 18 · 344 trades